Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting

  • Mathieu Nonnenmacher

Press/Media

Period16 May 2022

Media coverage

16

Media coverage

  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletMorningstar.com
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752218073&p=1gw&v=1&x=lPKlUbdhucUaz0crj2P1Cw
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual M
    Media name/outletStreet Insider
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752161718&p=1gw&v=1&x=DX88FDNg5RgSLPIbMBn8PA
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletTMC Net
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752241637&p=1gw&v=1&x=OK__1rLFuOC7EsPo3nazxA
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its …
    Media name/outletTMC Net
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752665918&p=1gw&v=1&x=HZrbzY8oZHmILE99RxcFkg
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752621733&p=1gw&v=1&x=8gfFY2kOzmxVBrtgrJb-OQ
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletADVFN UK
    Country/TerritoryUnited Kingdom
    Date16/05/22
    URLct.moreover.com/?a=47752178024&p=1gw&v=1&x=EGD2DWxIDNE5bpGnRb3Ffg
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletYahoo! Canada
    Country/TerritoryCanada
    Date16/05/22
    URLct.moreover.com/?a=47752201423&p=1gw&v=1&x=oYlF14WFrQlaXsNHgArwUg
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletYahoo! Finance
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752225929&p=1gw&v=1&x=AGyyaEhm-xfYaOZarmpP8g
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752160203&p=1gw&v=1&x=2Cb80YUq0_kJmgmwocNWUQ
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER(TM) Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletStockwatch
    Country/TerritoryCanada
    Date16/05/22
    URLct.moreover.com/?a=47752162389&p=1gw&v=1&x=9F9H51G-AeNw76YJwMiQ2g
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletMarket Newsdesk
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752182074&p=1gw&v=1&x=r8dpvI3ij0JoqGWKMAO9xQ
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletADVFN US
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752183997&p=1gw&v=1&x=7y0FEcj7SZdH70C4BBpAkw
    PersonsMathieu Nonnenmacher
  • TitleTo Present Preclinical Data from its Vectorized anti HER2 Antibody Program and a Novel AAV5 Derived TRACER Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date16/05/22
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletGlobeNewswire
    Country/TerritoryUnited States
    Date16/05/22
    URLct.moreover.com/?a=47752195587&p=1gw&v=1&x=xTtQa5-7zwhi_BOj2VSODw
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date16/05/22
    PersonsMathieu Nonnenmacher
  • TitleVoyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting
    Media name/outletBizWire Express
    Country/TerritoryIndia
    Date16/05/22
    URLct.moreover.com/?a=47752316721&p=1gw&v=1&x=pyzRPEjw5Db69dh7R1QoDA
    PersonsMathieu Nonnenmacher